BackNeurocrine Biosciences Overview
Neurocrine Biosciences, Inc.

Neurocrine Biosciences Target Price

Analysts' 12-month price predictions for NBIX.

Share Price

$145.88

Average Target Price

$167.5714.9% upside

7 analysts in the last 4 months

High: $193 | Low: $141

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-07-12Morgan StanleyJeffrey Hung$17016.5% upsideOpen
2024-06-06RBC CapitalBrian Abrahams$1413.3% downsideOpen
2024-05-28UBSAshwani Verma$19332.3% upsideOpen
2024-05-13Evercore ISICory Kasimov$17520% upsideOpen
2024-05-02Canaccord GenuitySumant Kulkarni$16412.4% upsideOpen
2024-05-02H.C. WainwrightAndrew Fein$1609.7% upsideOpen
2024-04-23Wells FargoMohit Bansal$17016.5% upsideOpen
2024-03-12OppenheimerJay Olson$20037.1% upsideOpen
2023-02-03Morgan Stanley$13010.9% downsideOpen
2022-11-02Robert W. BairdBrian Skorney$1502.8% upsideOpen
2022-11-02H.C. WainwrightAndrew Fein$1404% downsideOpen
2022-11-02Piper SandlerDavid Amsellem$10329.4% downsideOpen
2022-11-02SVB SecuritiesMarc Goodman$11521.2% downsideOpen
2022-02-14H.C. WainwrightAndrew Fein$1404% downsideOpen
2022-02-11Stifel NicolausPaul Matteis$1366.8% downsideOpen
2022-02-11Raymond JamesDanielle Brill$12514.3% downsideOpen
2022-02-11Leerink PartnersMarc Goodman$10031.5% downsideOpen
2022-02-11Robert W. BairdBrian Skorney$11719.8% downsideOpen
2022-01-26Bank of America SecuritiesTazeen Ahmad$12712.9% downsideOpen
2022-01-20BarclaysCarter Gould$10031.5% downsideOpen
2021-12-08CitigroupNeena Bitritto-Garg$12911.6% downsideOpen
2021-11-02Evercore ISIJoshua Schimmer$13010.9% downsideOpen
2021-11-02Cantor FitzgeraldCharles Duncan$12315.7% downsideOpen
2021-08-06Canaccord GenuitySumant Kulkarni$10826% downsideOpen
2021-08-04WedbushLaura Chico$11223.2% downsideOpen